|
US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
US5874424A
(en)
|
1995-12-20 |
1999-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US6008217A
(en)
|
1995-12-20 |
1999-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US4465679A
(en)
|
1983-01-31 |
1984-08-14 |
Usv Pharmaceutical Corporation |
1,2-Diaza-3-one compounds, their use in treating hypertension and pharmaceutical compositions thereof
|
|
IL72523A
(en)
|
1983-08-12 |
1988-06-30 |
Takeda Chemical Industries Ltd |
3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
|
|
US5055451A
(en)
|
1986-12-22 |
1991-10-08 |
Syntex Inc. |
Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
|
|
US5158936A
(en)
|
1986-12-22 |
1992-10-27 |
Syntex (U.S.A.) Inc. |
Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
|
|
US5008245A
(en)
|
1988-10-27 |
1991-04-16 |
University Of Kentucky Research Foundation |
Novel peptidyl carbamate inhibitors of the enzyme elastase
|
|
ZA905737B
(en)
|
1989-07-26 |
1991-05-29 |
Merrell Dow Pharma |
Novel peptidase inhibitors
|
|
NZ235155A
(en)
|
1989-09-11 |
1993-04-28 |
Merrell Dow Pharma |
Peptidase substrates in which the carboxy terminal group has been replaced by a tricarbonyl radical
|
|
AU7775991A
(en)
|
1990-04-04 |
1991-10-30 |
Immunex Corporation |
Interleukin 1beta protease
|
|
US5416013A
(en)
|
1990-04-04 |
1995-05-16 |
Sterling Winthrop Inc. |
Interleukin 1β protease and interleukin 1β protease inhibitors
|
|
DE59209540D1
(de)
|
1991-03-15 |
1998-12-03 |
Hoechst Ag |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
DE69226820T2
(de)
*
|
1991-06-21 |
1999-05-12 |
Merck & Co., Inc., Rahway, N.J. |
Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen
|
|
JP3190431B2
(ja)
|
1991-07-01 |
2001-07-23 |
三菱化学株式会社 |
ケトン誘導体
|
|
EP0533226A3
(en)
|
1991-08-16 |
1993-08-18 |
Merck & Co. Inc. |
Novel chromophore containing compounds
|
|
US5278061A
(en)
|
1991-08-16 |
1994-01-11 |
Merck & Co., Inc. |
Affinity chromatography matrix useful in purifying interleukin-1β converting enzyme
|
|
US6348570B1
(en)
|
1991-08-16 |
2002-02-19 |
Merck & Co., Inc. |
Chromophore containing compounds and their use in determining interleukin-1β convertase activity
|
|
EP0600880B1
(en)
|
1991-08-30 |
2004-01-07 |
Vertex Pharmaceuticals Incorporated |
Interleukin 1- beta protease and interleukin 1-beta protease inhibitors
|
|
EP0541946B1
(de)
|
1991-10-07 |
1996-07-17 |
Hoechst Aktiengesellschaft |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
GB9123326D0
(en)
|
1991-11-04 |
1991-12-18 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
EP0547699A1
(en)
|
1991-12-19 |
1993-06-23 |
Merck & Co. Inc. |
Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme
|
|
WO1993014777A1
(en)
|
1992-01-31 |
1993-08-05 |
Merck & Co., Inc. |
PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
|
|
EP0627926B1
(en)
|
1992-02-21 |
1998-08-05 |
Merck & Co., Inc. (a New Jersey corp.) |
PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
|
|
AU4634993A
(en)
|
1992-06-24 |
1994-01-24 |
Merck & Co., Inc. |
Dna encoding precursor interleukin 1beta converting enzyme
|
|
JP2602181B2
(ja)
|
1992-07-31 |
1997-04-23 |
ファイザー・インク. |
消炎薬としてのペプチジル4−アミノ−2,2−ジフルオロ−3−オクソ−1,6−ヘキサン二酸誘導体
|
|
CA2109646C
(en)
|
1992-11-24 |
2000-03-07 |
Gaston O. Daumy |
Para-nitroanilide peptides
|
|
EP0618223A3
(en)
|
1993-03-08 |
1996-06-12 |
Sandoz Ltd |
Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents.
|
|
TW494094B
(en)
|
1993-04-29 |
2002-07-11 |
Vertex Pharma |
Peptide analogs as irreversible interleukin-1β protease inhibitors and pharmaceutical compositions comprising the same
|
|
US5462939A
(en)
|
1993-05-07 |
1995-10-31 |
Sterling Winthrop Inc. |
Peptidic ketones as interleukin-1β-converting enzyme inhibitors
|
|
US5411985A
(en)
|
1993-05-17 |
1995-05-02 |
Merck & Co., Inc. |
Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 β inventory enzyme
|
|
JPH0789951A
(ja)
|
1993-06-03 |
1995-04-04 |
Sterling Winthrop Inc |
インターロイキン−1β転換酵素阻害剤
|
|
JPH0725887A
(ja)
|
1993-06-04 |
1995-01-27 |
Sterling Winthrop Inc |
インターロイキン−1β転換酵素阻害剤
|
|
WO1995005192A1
(en)
|
1993-08-13 |
1995-02-23 |
Merck & Co., Inc. |
SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
|
|
US5486623A
(en)
|
1993-12-08 |
1996-01-23 |
Prototek, Inc. |
Cysteine protease inhibitors containing heterocyclic leaving groups
|
|
US5714484A
(en)
|
1993-12-08 |
1998-02-03 |
Prototek, Inc. |
α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
|
|
EP0752987B1
(en)
|
1994-03-31 |
2003-11-12 |
Vertex Pharmaceuticals Incorporated |
Pyrimidinyl derivatives as interleukin inhibitors
|
|
FI964342A0
(fi)
|
1994-04-29 |
1996-10-28 |
Sanofi Winthrop Inc |
Halogeenimetyyliamideja IL-1beta-proteaasi-inhibiittoreina
|
|
US5492824A
(en)
|
1994-05-12 |
1996-02-20 |
Basf Ag |
Ice and ice-like compositions and methods of making same
|
|
US5552400A
(en)
|
1994-06-08 |
1996-09-03 |
Sterling Winthrop Inc. |
Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
|
|
US5756466A
(en)
|
1994-06-17 |
1998-05-26 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
|
US5856116A
(en)
|
1994-06-17 |
1999-01-05 |
Vertex Pharmaceuticals, Incorporated |
Crystal structure and mutants of interleukin-1 beta converting enzyme
|
|
US6420522B1
(en)
|
1995-06-05 |
2002-07-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US5716929A
(en)
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
|
US5847135A
(en)
|
1994-06-17 |
1998-12-08 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US5565430A
(en)
|
1994-08-02 |
1996-10-15 |
Sterling Winthrop Inc. |
Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
|
|
US5498616A
(en)
|
1994-11-04 |
1996-03-12 |
Cephalon, Inc. |
Cysteine protease and serine protease inhibitors
|
|
TW394764B
(en)
|
1995-02-14 |
2000-06-21 |
Mitsubishi Chemcal Corp |
Oxygen-containing heterocyclic derivatives
|
|
WO1996030395A2
(en)
|
1995-03-31 |
1996-10-03 |
Takeda Chemical Industries, Ltd. |
Cysteine protease inhibitor
|
|
US5798442A
(en)
|
1995-04-21 |
1998-08-25 |
Merck Frosst Canada, Inc. |
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
|
|
EP0851760A4
(en)
|
1995-08-31 |
1998-11-25 |
Smithkline Beecham Corp |
INTERLEUKIN CONVERSION ENZYME AND APOPTOSIS
|
|
JPH11511463A
(ja)
|
1995-08-31 |
1999-10-05 |
スミスクライン・ビーチャム・コーポレイション |
インターロイキン変換酵素およびアポプトーシス
|
|
US5744451A
(en)
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
|
EP0761680A3
(en)
|
1995-09-12 |
1999-05-06 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
|
|
WO1997024339A1
(en)
|
1995-12-27 |
1997-07-10 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole derivatives and drugs containing the same as the active ingredient
|
|
AU3359697A
(en)
|
1996-07-08 |
1998-02-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Bone resorption inhibitors
|
|
WO1998004539A1
(en)
|
1996-07-29 |
1998-02-05 |
Mitsubishi Chemical Corporation |
Oxygenic heterocyclic derivatives
|
|
US6200969B1
(en)
|
1996-09-12 |
2001-03-13 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US6531467B2
(en)
|
1996-09-12 |
2003-03-11 |
Idun Pharmaceuticals, Inc. |
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US5869519A
(en)
|
1996-12-16 |
1999-02-09 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6610683B2
(en)
|
1996-09-12 |
2003-08-26 |
Idun Pharmaceuticals, Inc. |
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
CA2265853C
(en)
|
1996-09-12 |
2010-08-03 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ice)/ced-3 family inhibitors
|
|
NZ334605A
(en)
|
1996-09-12 |
2000-08-25 |
Idun Pharmaceuticals Inc |
C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and for treatments of inflammatory, autoimmune, neurodegenerative disorders and in the prevention of ischemic injury
|
|
EP0874850B1
(en)
|
1996-09-12 |
2002-04-10 |
Idun Pharmaceuticals, Inc. |
Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
|
|
US5968927A
(en)
|
1996-09-20 |
1999-10-19 |
Idun Pharmaceuticals, Inc. |
Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
|
|
WO1998016504A2
(en)
|
1996-10-11 |
1998-04-23 |
Warner-Lambert Company |
SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
|
|
JP2001508404A
(ja)
|
1996-10-11 |
2001-06-26 |
ワーナー―ランバート・コンパニー |
スルホンアミドインターロイキン―1β変換酵素阻害剤
|
|
US5919790A
(en)
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
|
WO1998016502A1
(en)
|
1996-10-11 |
1998-04-23 |
Warner-Lambert Company |
ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
|
|
US5877197A
(en)
|
1996-12-16 |
1999-03-02 |
Karanewsky; Donald S. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6054487A
(en)
*
|
1997-03-18 |
2000-04-25 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
HUP9700816A3
(en)
|
1997-04-28 |
1999-06-28 |
Gyogyszerkutato Intezet |
3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta
|
|
US6184210B1
(en)
|
1997-10-10 |
2001-02-06 |
Cytovia, Inc. |
Dipeptide apoptosis inhibitors and the use thereof
|
|
JP2002509153A
(ja)
|
1998-01-20 |
2002-03-26 |
ワーナー−ランバート・カンパニー |
インターロイキン−1β変換酵素(ICE)のインビボ阻害剤としてのN−[2−(5−ベンジルオキシカルボニル−アミノ−6−オキソ−2−(4−フルオロフェニル)−1,6−ジヒドロ−1−ピリミジニル)アセトキシル]−L−アスパラギン酸アルデヒド
|
|
KR20010041905A
(ko)
|
1998-03-16 |
2001-05-25 |
시토비아 인크. |
디펩티드 카스파제 억제제 및 이의 용도
|
|
RU2274642C2
(ru)
|
1998-03-19 |
2006-04-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы каспаз
|
|
IL139416A0
(en)
|
1998-05-05 |
2001-11-25 |
Warner Lambert Company Basf Ag |
Succinamide inhibitors of interleukin-1? converting enzyme
|
|
US6197750B1
(en)
|
1998-07-02 |
2001-03-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
EP1165490B1
(en)
|
1999-03-16 |
2006-08-16 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
EP1163214A1
(en)
|
1999-03-16 |
2001-12-19 |
Merck Frosst Canada & Co. |
Gamma-ketoacid dipeptides as inhibitors of caspase-3
|
|
ATE363465T1
(de)
|
1999-04-09 |
2007-06-15 |
Cytovia Inc |
Caspase inhibitoren und ihre verwendung
|
|
EP1202976B1
(en)
|
1999-07-19 |
2006-11-02 |
Merck Frosst Canada Ltd. |
Pyrazinones, compositions containing such compounds
|
|
DE60010675T2
(de)
|
1999-08-06 |
2005-06-16 |
Vertex Pharmaceuticals Inc., Cambridge |
Caspase inhibitoren und deren verwendung
|
|
EA200200301A1
(ru)
|
1999-08-27 |
2002-08-29 |
Сайтовиэ, Инк. |
ЗАМЕЩЕННЫЕ α-ГИДРОКСИКИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ИНГИБИРОВАНИЯ КЛЕТОЧНОЙ ГИБЕЛИ НА КЛЕТОЧНОМ ИЛИ ТКАНЕВОМ УРОВНЕ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ОБЛЕГЧЕНИЯ СОСТОЯНИЯ ПРИ ГИБЕЛИ КЛЕТОК У ЖИВОТНОГО, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАЗЛИЧНЫХ БОЛЕЗНЕЙ
|
|
US6566338B1
(en)
|
1999-10-12 |
2003-05-20 |
Cytovia, Inc. |
Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
|
|
AR026748A1
(es)
|
1999-12-08 |
2003-02-26 |
Vertex Pharma |
Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
|
|
MXPA02009633A
(es)
|
2000-03-29 |
2003-03-10 |
Vertex Pharma |
Inhibidores de carbamato caspasa y usos de los mismos.
|
|
RU2002135314A
(ru)
|
2000-05-04 |
2004-05-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Асимметричный синтез пиперазиновой кислоты и ее производных
|
|
PE20011350A1
(es)
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
|
MXPA02000823A
(es)
|
2000-05-23 |
2002-07-30 |
Vertex Pharma |
Inhibidores de caspasa y uso de los mismos.
|
|
WO2001094351A1
(en)
|
2000-06-07 |
2001-12-13 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
CA2315468A1
(en)
|
2000-08-10 |
2002-02-10 |
Thermax International Corp. |
Multi grouting system
|
|
WO2002022611A2
(en)
|
2000-09-13 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
WO2002042278A2
(en)
|
2000-11-21 |
2002-05-30 |
Vertex Pharmaceuticals Incorporated |
Imidazole and benzimidazole caspase inhibitors and uses thereof
|
|
MXPA03009647A
(es)
|
2001-04-19 |
2004-01-29 |
Vertex Pharma |
Heterociclildicarbamidas como inhibidores de caspasa.
|
|
CA2445923A1
(en)
|
2001-05-10 |
2002-11-14 |
Abbott Gmbh & Co. Kg |
Arylsulfonamide ethers, and methods of use thereof
|
|
WO2002094263A2
(en)
|
2001-05-23 |
2002-11-28 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
WO2003042169A2
(en)
|
2001-10-09 |
2003-05-22 |
Vertex Pharmaceuticals Incorporated |
Process for synthesizing aspartic and glutamic acid derivatives and diazoketone intermediates thereof
|
|
WO2003072528A2
(en)
|
2002-02-08 |
2003-09-04 |
Idun Pharmaceuticals, Inc. |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
WO2003068242A1
(en)
|
2002-02-11 |
2003-08-21 |
Vertex Pharmaceuticals Incorporated |
Phospholipids as caspase inhibitor prodrugs
|
|
WO2004002401A2
(en)
|
2002-04-05 |
2004-01-08 |
Cytovia, Inc. |
Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
|
|
US7960398B2
(en)
|
2002-04-19 |
2011-06-14 |
Vertex Pharmaceuticals Incorporated |
Regulation of TNF-alpha
|
|
US7001899B2
(en)
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
|
US7138395B2
(en)
|
2002-06-10 |
2006-11-21 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
US7041696B2
(en)
|
2002-06-17 |
2006-05-09 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
US7553852B2
(en)
|
2002-06-28 |
2009-06-30 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
AU2003303345A1
(en)
|
2002-12-20 |
2004-07-22 |
Vertex Pharmaceuticals, Inc. |
4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
|
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
|
WO2005047906A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Vertex Pharmaceuticals Incorporated |
Methods for monitoring il-18
|
|
US20050233974A1
(en)
|
2003-12-01 |
2005-10-20 |
John Randle |
Treating infectious diseases using ice inhibitors
|
|
AR047981A1
(es)
*
|
2004-02-27 |
2006-03-15 |
Vertex Pharma |
Inhibidores de caspasa y sus usos correspondientes
|
|
CA2566362C
(en)
|
2004-05-15 |
2013-09-10 |
Vertex Pharmaceuticals Incorporated |
Treating seizures using ice inhibitors
|
|
CA2568352C
(en)
*
|
2004-06-04 |
2011-09-13 |
Regeneron Pharmaceuticals, Inc. |
Methods of using il-1 antagonists to treat autoinflammatory disease
|